Kiniksa Pharmaceuticals International, plc

SecurityKNSA / Kiniksa Pharmaceuticals International, plc
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership474,750 shares
Latest Disclosed Value $ 22,859,213
Citadel Advisors Llc ownership in KNSA / Kiniksa Pharmaceuticals International, plc

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 474,750 shares of Kiniksa Pharmaceuticals International, plc (US:KNSA) valued at $22,859,212 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 742,118 shares of Kiniksa Pharmaceuticals International, plc. This represents a change in shares of -36.03% during the quarter. The current value of the position is $22,987,395 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (KNSA) in the form of stock options. The firm currently holds call options representing 13,100 of underlying shares valued at $630,765 USD and put options representing 11,800 of underlying shares valued at $568,170 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KNSA / Kiniksa Pharmaceuticals International, plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 474,750 -267,368 -36.03 22,859 -25.33 0.0033
2026-02-17 2025-12-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 742,118 427,562 135.93 30,612 150.63 0.0046
2025-11-14 2025-09-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 314,556 47,163 17.64 12,214 65.10 0.0019
2025-08-14 2025-06-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 267,393 206,746 340.90 7,399 449.63 0.0013
2025-05-15 2025-03-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 60,647 -243,929 -80.09 1,347 -77.66 0.0003
2025-02-14 2024-12-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 304,576 106,163 53.51 6,025 21.50 0.0010
2024-11-14 2024-09-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 198,413 143,593 261.94 4,958 384.65 0.0010
2024-08-14 2024-06-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 54,820 54,820 1,023 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 13,100 631 n/a n/a n/a
2026-02-17 2025-12-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 14,100 -56.21 548 -38.54 n/a n/a n/a
2025-08-14 2025-06-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 32,200 166.12 891 232.09 n/a n/a n/a
2025-05-15 2025-03-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 12,100 128.30 269 157.69 n/a n/a n/a
2025-02-14 2024-12-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 5,300 -45.36 105 -57.02 n/a n/a n/a
2024-11-14 2024-09-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 9,700 22.78 242 64.63 n/a n/a n/a
2024-08-14 2024-06-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Call 7,900 147 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 11,800 -2.48 568 13.83 n/a n/a n/a
2026-02-17 2025-12-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 12,100 47.56 499 56.92 n/a n/a n/a
2025-11-14 2025-09-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 8,200 318 n/a n/a n/a
2025-08-14 2025-06-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 5,600 36.59 124 53.09 n/a n/a n/a
2025-02-14 2024-12-31 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 4,100 -35.94 81 -49.06 n/a n/a n/a
2024-11-14 2024-09-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 6,400 611.11 160 893.75 n/a n/a n/a
2024-08-14 2024-06-30 13F KINIKSA PHARMACEUTICALS INTL ORD SHS CL A Put 900 17 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.